- One more new gastric disease induced by Helicobacter pylori infection, enterochromaffin-like (ECL) cell carcinoid tumor. Chiba, Tsutomu // Journal of Gastroenterology;1999, Vol. 34 Issue 4, p545
Editorial. Emphasizes the possibility of a gastric disease induced by Helicobacter pylori infection and enterochromaffin-like cell carcinoid tumor. Why the pylori infection enhances carcinoid tumor infection more in Mongolian gerbil than in humans; Importance of suppression of acid secretion...
- Does Helicobacter pylori really cause duodenal ulcers? YES. Ford, Alexander C.; Talley, Nicholas J. // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;9/5/2009, Vol. 339 Issue 7720, p542
The article argues that Helicobacter pylori causes duodenal ulcers. The authors claim that since Helicobacter pylori infects the human stomach, it can cause antral or corpus predominant gastritis and duodenal ulcer. They add that patients who develop duodenal ulcer have Helicobacter pylori...
- Duodenal ulcer: the villain unmasked? Axon, A.R. // BMJ: British Medical Journal (International Edition);4/20/91, Vol. 302 Issue 6782, p919
Examines the treatment of duodenal ulcer by eradicating helicobacter pylori. Domination of the surgical treatment of duodenal ulcer disease; Prevalence of helicobacter infection and associated chronic gastritis; Association of antral gastritis and duodenal ulcer.
- Eradicating H. pylori-induced ulcers. R.M.D. // Cortlandt Forum;7/25/96, Vol. 9 Issue 7, p81
Recommends the use of an H2 blocker in treating Helicobacter pylori-induced duodenal ulcers.
- Helicobacter pylori Infection Rates in Duodenal Ulcer Patients in the United States May Be Lower Than Previously Estimated. Ciociola, Arthur A.; McSorley, David J.; Turner, Kathryn; Sykes, Deborah; Palmer, James B. D. // American Journal of Gastroenterology;Jul1999, Vol. 94 Issue 7, p1834
Reports on Helicobacter pylori infection rates in duodenal ulcer patients in the U.S. Etiology and epidemiology of duodenal ulcer; Assessment of the H. pylori prevalence rates; Total number of patients included in the study population; Study design.
- Ulcers and bacteria--the role of H. pylori. // American Family Physician;11/1/1995, Vol. 52 Issue 6, p1729
Cites the role of Helicobacter pylori in the development of peptic ulcers. Importance of treating H. pylori infection; All patients with stomach and duodenal ulcers as needing HH. pylori infection treatment; Antibiotic treatment for H. pylori infection.
- Factors Associated with Helicobacter pylori Infection by a cagA-Positive Strain in Children. Queiroz, Dulciene M.M.; Mendes, Edilberto N.; Carvalho, Anfrisina S.T.; Rocha, Gifone A.; Oliveira, Andreia M.R.; Soares, Taciana F.; Santos, Adriana; Cabral, Monica M.D.A.; Nogueira, Ana M.M.F. // Journal of Infectious Diseases;2/1/2000, Vol. 181 Issue 2, p626
Studies factors associated with Helicobacter pylori infection by a cagA-positive strain in children. Essential factor in the pathogenesis of duodenal peptic ulcer; Relationship between ulcerogenesis and infection with a cagA-positive Helicobacter pylori strain in children; Characteristics of...
- A revolution in peptic ulcer disease. Cerda, James J.; Go, Mae F. // Patient Care;5/15/1994, Vol. 28 Issue 9, p18
Presents evidence for the involvement of Helicobacter pylori in the development of gastric and duodenal ulcers. Diagnosis for H. pylori infection in peptic ulcers; Symptoms associated with peptic ulcers; Antibiotic therapy for H. pylori infections; Eradication and relapse of ulcers. INSETS:...
- Inactive duodenal ulcers still deserve antibiotic therapy when H pylori present. // Modern Medicine;Apr97, Vol. 65 Issue 4, p21
Reports that ulcer patients who are positive for Helicobacter pylori should undergo antibiotic therapy to eradicate the bacteria even if their ulcer is inactive. Treatment of H. pylori infection as a surrogate marker for the prevention of duodenal ulcer disease; Management of patients who have...
- Combination ulcer therapy in single tablet. // Geriatrics;Jan97, Vol. 52 Issue 1, p16
Discusses the use of ranitidine bismuth citrate with charithromycin in the treatment of duodenal ulcer associated with Helicobacter pylori infection. Eradication rate; Dosage; Contraindications; Adverse effects.